Indication For the acute treatment of intermittent,stereotypic episodes of frequent seizure activity (i.e.seizure clusters,acute repetitive seizures)that are distinct from a patient’s usual seizure pattern in patients with epilepsy 6 years of age and older.
Indication For the control of serumphos phorus(sP) levels in adults with chronic kidney disease (CKD) on hemodialysis or peritoneal dialysis,and for the control of sP levels in paediatric patients 12 years of age and older with CKD stages 4-5 (defined as glomerular filtration rate < 30mL/min/1.73m² ) or CKD on dialysis.
Indication For intravenous treatment of patients with acute decompensated heart failure with difficulty in breathing during rest or mild activity. NYHA class should be greater than Class II
Indication – Mild-to-moderate depression and anxiety – Neurasthenia, psychogenic depression, depressive neuroses, masked depression, psychosomatic affections accompanied by anxiety and apathy, menopausal depressions, dysphoria and depression in alcoholics and drug- addicts
Indication For the long-term treatment of coronary heart disease, prevention of vasospasm and mixed angina, also for the treatment after myocardial infarction and long-term treatment of chronic heart failure
